• Je něco špatně v tomto záznamu ?

Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies

L. Chinitz, P. Ritter, SK. Khelae, S. Iacopino, C. Garweg, M. Grazia-Bongiorni, P. Neuzil, JB. Johansen, L. Mont, E. Gonzalez, V. Sagi, GZ. Duray, N. Clementy, T. Sheldon, V. Splett, K. Stromberg, N. Wood, C. Steinwender,

. 2018 ; 15 (9) : 1363-1371. [pub] 20180511

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012671

BACKGROUND: Micra is a leadless pacemaker that is implanted in the right ventricle and provides rate response via a 3-axis accelerometer (ACC). Custom software was developed to detect atrial contraction using the ACC enabling atrioventricular (AV) synchronous pacing. OBJECTIVE: The purpose of this study was to sense atrial contractions from the Micra ACC signal and provide AV synchronous pacing. METHODS: The Micra Accelerometer Sensor Sub-Study (MASS) and MASS2 early feasibility studies showed intracardiac accelerations related to atrial contraction can be measured via ACC in the Micra leadless pacemaker. The Micra Atrial TRacking Using A Ventricular AccELerometer (MARVEL) study was a prospective multicenter study designed to characterize the closed-loop performance of an AV synchronous algorithm downloaded into previously implanted Micra devices. Atrioventricular synchrony (AVS) was measured during 30 minutes of rest and during VVI pacing. AVS was defined as a P wave visible on surface ECG followed by a ventricular event <300 ms. RESULTS: A total of 64 patients completed the MARVEL study procedure at 12 centers in 9 countries. Patients were implanted with a Micra for a median of 6.0 months (range 0-41.4). High-degree AV block was present in 33 patients, whereas 31 had predominantly intrinsic conduction during the study. Average AVS during AV algorithm pacing was 87.0% (95% confidence interval 81.8%-90.9%), 80.0% in high-degree block patients and 94.4% in patients with intrinsic conduction. AVS was significantly greater (P <.001) during AV algorithm pacing compared to VVI in high-degree block patients, whereas AVS was maintained in patients with intrinsic conduction. CONCLUSION: Accelerometer-based atrial sensing is feasible and significantly improves AVS in patients with AV block and a single-chamber leadless pacemaker implanted in the right ventricle.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012671
003      
CZ-PrNML
005      
20190409151416.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.hrthm.2018.05.004 $2 doi
035    __
$a (PubMed)29758405
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chinitz, Larry $u NYU Langone Medical Center, New York, New York. Electronic address: larry.chinitz@nyumc.org.
245    10
$a Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies / $c L. Chinitz, P. Ritter, SK. Khelae, S. Iacopino, C. Garweg, M. Grazia-Bongiorni, P. Neuzil, JB. Johansen, L. Mont, E. Gonzalez, V. Sagi, GZ. Duray, N. Clementy, T. Sheldon, V. Splett, K. Stromberg, N. Wood, C. Steinwender,
520    9_
$a BACKGROUND: Micra is a leadless pacemaker that is implanted in the right ventricle and provides rate response via a 3-axis accelerometer (ACC). Custom software was developed to detect atrial contraction using the ACC enabling atrioventricular (AV) synchronous pacing. OBJECTIVE: The purpose of this study was to sense atrial contractions from the Micra ACC signal and provide AV synchronous pacing. METHODS: The Micra Accelerometer Sensor Sub-Study (MASS) and MASS2 early feasibility studies showed intracardiac accelerations related to atrial contraction can be measured via ACC in the Micra leadless pacemaker. The Micra Atrial TRacking Using A Ventricular AccELerometer (MARVEL) study was a prospective multicenter study designed to characterize the closed-loop performance of an AV synchronous algorithm downloaded into previously implanted Micra devices. Atrioventricular synchrony (AVS) was measured during 30 minutes of rest and during VVI pacing. AVS was defined as a P wave visible on surface ECG followed by a ventricular event <300 ms. RESULTS: A total of 64 patients completed the MARVEL study procedure at 12 centers in 9 countries. Patients were implanted with a Micra for a median of 6.0 months (range 0-41.4). High-degree AV block was present in 33 patients, whereas 31 had predominantly intrinsic conduction during the study. Average AVS during AV algorithm pacing was 87.0% (95% confidence interval 81.8%-90.9%), 80.0% in high-degree block patients and 94.4% in patients with intrinsic conduction. AVS was significantly greater (P <.001) during AV algorithm pacing compared to VVI in high-degree block patients, whereas AVS was maintained in patients with intrinsic conduction. CONCLUSION: Accelerometer-based atrial sensing is feasible and significantly improves AVS in patients with AV block and a single-chamber leadless pacemaker implanted in the right ventricle.
650    _2
$a akcelerometrie $x přístrojové vybavení $7 D061725
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a atrioventrikulární blokáda $x patofyziologie $x terapie $7 D054537
650    _2
$a elektrokardiografie $x metody $7 D004562
650    _2
$a design vybavení $7 D004867
650    _2
$a studie proveditelnosti $7 D005240
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a srdeční síně $x patofyziologie $7 D006325
650    _2
$a srdeční frekvence $x fyziologie $7 D006339
650    _2
$a srdeční komory $x patofyziologie $7 D006352
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a kardiostimulátor $7 D010138
650    _2
$a prospektivní studie $7 D011446
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ritter, Philippe $u Hopital Du Haut Leveque, Pessac, France.
700    1_
$a Khelae, Surinder Kaur $u Institut Jantung Negara, Selangor, Malaysia.
700    1_
$a Iacopino, Saverio $u GVM Care and Research, Lamezia Terma, Italy.
700    1_
$a Garweg, Christophe $u UZ Leuven, Diegem, Belgium.
700    1_
$a Grazia-Bongiorni, Maria $u University Hospital of Pisa, Pisa, Italy.
700    1_
$a Neuzil, Petr $u Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Johansen, Jens Brock $u Odense University Hospital, Odense, Denmark.
700    1_
$a Mont, Lluis $u Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.
700    1_
$a Gonzalez, Efrain $u Baptist Hospital of Miami, Miami, Florida.
700    1_
$a Sagi, Venkata $u Southern Heart Group, Jacksonville, Florida.
700    1_
$a Duray, Gabor Z $u Military Hospital-State Health Center, Budapest, Hungary.
700    1_
$a Clementy, Nicolas $u CHU de Tours, Chambray-les-Tours, France.
700    1_
$a Sheldon, Todd $u Medtronic, plc, Mounds View, Minnesota.
700    1_
$a Splett, Vincent $u Medtronic, plc, Mounds View, Minnesota.
700    1_
$a Stromberg, Kurt $u Medtronic, plc, Mounds View, Minnesota.
700    1_
$a Wood, Nicole $u Medtronic, plc, Mounds View, Minnesota.
700    1_
$a Steinwender, Clemens $u Department of Cardiology, Kepler University Hospital, Linz, Austria; Paracelsus Medical University Salzburg, Salzburg, Austria.
773    0_
$w MED00156180 $t Heart rhythm $x 1556-3871 $g Roč. 15, č. 9 (2018), s. 1363-1371
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29758405 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190409151431 $b ABA008
999    __
$a ok $b bmc $g 1391981 $s 1050976
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 15 $c 9 $d 1363-1371 $e 20180511 $i 1556-3871 $m Heart rhythm $n Heart Rhythm $x MED00156180
LZP    __
$a Pubmed-20190405
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace